P2 Science

company

About

P2 Science develops a bio-refining process for the conversion of biomass such as vegetable oils into high-value specialty chemicals.

  • 1 - 10

Details

Last Funding Type
Convertable Note
Industries
Biotechnology,Chemical,Renewable Energy
Founded date
Jan 1, 2009
Number Of Employee
1 - 10
Operating Status
Active

P2 Science a venture-backed, renewable specialty chemicals company, co-founded by Yale scientists, a chemical industry CEO and Elm Street Ventures, an early-stage venture fund.

P2 Science has developed a unique process technology for converting renewable feedstocks—including vegetable oils—into high-value, specialty chemicals. These include flavor, fragrance and cosmetics ingredients. Many of their products are today available only from petrochemical sources. Among the first products to be produced by P2 are vegetable-derived, cost-effective versions of current petrochemical fragrance ingredients. Major users and formulators of specialty chemicals have a strong interest in substituting renewable for petrochemical ingredients.

Patrick Foley, a Yale graduate of the PhD program in Environmental Engineering, is P2′s Chief Scientific Officer. Neil Burns, an executive with 20+ years experience in the specialty chemical industry, is the company’s CEO.

P2 has a laboratory in New Haven, CT to support this technology’s development and commercialization, as well as partnerships with major companies at a number of points along the supply chain.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$22.55M
P2 Science has raised a total of $22.55M in funding over 2 rounds. Their latest funding was raised on Jan 29, 2020 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 29, 2020 Series C $12M 1 Detail
Dec 12, 2018 Series Unknown 1 Detail
Mar 1, 2017 Series B $9.55M 1 Detail
Aug 26, 2016 Debt Financing 1 Detail
Mar 2, 2016 Convertable Note 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
P2 Science is funded by 2 investors. Advantage Capital and Eli Whitney Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Advantage Capital Series C
Eli Whitney Fund Series A